Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-alpha. 1992

S Wu, and K Rodabaugh, and O Martinez-Maza, and J M Watson, and D S Silberstein, and C M Boyer, and W P Peters, and J B Weinberg, and J S Berek, and R C Bast
Department of Medicine, Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, NC 27710.

OBJECTIVE We investigated whether monocyte-derived factors could stimulate the growth of ovarian cancer cells. METHODS Human peripheral blood monocytes or human monocyte-like cell lines THP-1 and U-937 were cultured with or without macrophage colony-stimulating factor, lipopolysaccharide, or phorbol myristate acetate. Culture supernatants or recombinant cytokines were assayed for growth stimulation of ovarian cancer cell lines by tritium-thymidine incorporation and direct cell counts followed by statistical analysis with Student t test. RESULTS Conditioned medium from peripheral blood monocytes or from THP-1 or U-937 cells stimulated ovarian cancer cell growth. Interleukin-1 alpha, tumor necrosis factor-alpha, and interleukin-6 also stimulated ovarian cancer cell growth, whereas macrophage, granulocyte, and granulocyte-macrophage colony-stimulating factor did not. Concentrations of tumor necrosis factor, interleukin-1, and interleukin-6 in conditioned medium could not account for all the growth stimulation, and activity remained after neutralization of tumor necrosis factor, interleukin-1, and interleukin-6 with antibodies. CONCLUSIONS Interleukin-1, interleukin-6, tumor necrosis factor, and additional monocyte factor(s) could provide paracrine growth stimulation when monocytes are attracted to ovarian cancers that produce macrophage colony-stimulating factor.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013755 Tetradecanoylphorbol Acetate A phorbol ester found in CROTON OIL with very effective tumor promoting activity. It stimulates the synthesis of both DNA and RNA. Phorbol Myristate Acetate,12-Myristoyl-13-acetylphorbol,12-O-Tetradecanoyl Phorbol 13-Acetate,Tetradecanoylphorbol Acetate, 4a alpha-Isomer,12 Myristoyl 13 acetylphorbol,12 O Tetradecanoyl Phorbol 13 Acetate,13-Acetate, 12-O-Tetradecanoyl Phorbol,Acetate, Phorbol Myristate,Acetate, Tetradecanoylphorbol,Myristate Acetate, Phorbol,Phorbol 13-Acetate, 12-O-Tetradecanoyl,Tetradecanoylphorbol Acetate, 4a alpha Isomer
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

S Wu, and K Rodabaugh, and O Martinez-Maza, and J M Watson, and D S Silberstein, and C M Boyer, and W P Peters, and J B Weinberg, and J S Berek, and R C Bast
December 1990, Journal of cellular biochemistry,
S Wu, and K Rodabaugh, and O Martinez-Maza, and J M Watson, and D S Silberstein, and C M Boyer, and W P Peters, and J B Weinberg, and J S Berek, and R C Bast
October 1995, Infection and immunity,
S Wu, and K Rodabaugh, and O Martinez-Maza, and J M Watson, and D S Silberstein, and C M Boyer, and W P Peters, and J B Weinberg, and J S Berek, and R C Bast
July 1994, American journal of perinatology,
S Wu, and K Rodabaugh, and O Martinez-Maza, and J M Watson, and D S Silberstein, and C M Boyer, and W P Peters, and J B Weinberg, and J S Berek, and R C Bast
December 1992, American journal of obstetrics and gynecology,
S Wu, and K Rodabaugh, and O Martinez-Maza, and J M Watson, and D S Silberstein, and C M Boyer, and W P Peters, and J B Weinberg, and J S Berek, and R C Bast
October 1993, Cancer,
S Wu, and K Rodabaugh, and O Martinez-Maza, and J M Watson, and D S Silberstein, and C M Boyer, and W P Peters, and J B Weinberg, and J S Berek, and R C Bast
August 1993, Lymphokine and cytokine research,
S Wu, and K Rodabaugh, and O Martinez-Maza, and J M Watson, and D S Silberstein, and C M Boyer, and W P Peters, and J B Weinberg, and J S Berek, and R C Bast
December 1989, Clinical immunology and immunopathology,
S Wu, and K Rodabaugh, and O Martinez-Maza, and J M Watson, and D S Silberstein, and C M Boyer, and W P Peters, and J B Weinberg, and J S Berek, and R C Bast
November 1987, Journal of immunology (Baltimore, Md. : 1950),
S Wu, and K Rodabaugh, and O Martinez-Maza, and J M Watson, and D S Silberstein, and C M Boyer, and W P Peters, and J B Weinberg, and J S Berek, and R C Bast
June 1991, Cancer research,
S Wu, and K Rodabaugh, and O Martinez-Maza, and J M Watson, and D S Silberstein, and C M Boyer, and W P Peters, and J B Weinberg, and J S Berek, and R C Bast
May 1990, European journal of immunology,
Copied contents to your clipboard!